Adam Carrera, PharmD (he/him/his)

Associate Director, Scientific Communications & HEOR
Urovant Sciences
Irvine, California, United States

Presentation(s):

• Real-World Adherence and Persistence of Vibegron Versus Oral Overactive Bladder Treatments

  Thursday, October 5, 2023
  4:16 PM – 4:20 PM US PST

  Disclosure(s): Urovant Sciences: Employee (Ongoing)